Dr. Anne Lynn Su Chang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-6316 |
Shehla Admani, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Dr. Maria Susana Ortiz Urda, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 Blake Wilbur Drive, Stanford, CA 94305 Phone: 650-723-6316 Fax: 650-723-7796 |
Dr. Alfred Thomas Lane, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 900 Blake Wilbur Dr., W0071, Stanford, CA 94305 Phone: 650-723-6105 |
Saisindhu Narala, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Michelle Hanjani Galant, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Christina M Danial, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Dr. Hayley Wheeler Leatham, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Dr. Caely Alise Hambro Yanikoglu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
David Jun Sing Wong, MD, PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Roberto Andres Novoa, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Dr. Jennifer Elynn Yeh, MD, PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Matt Peter Marinkovich, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 269 Campus Dr, 2145, Stanford, CA 94305 Phone: 650-498-5425 |
Jason Ya, MD Dermatology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Kevin Chun-kai Wang, MD Dermatology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Dr. Phuong Khuu, M.D. Dermatology - Pediatric Dermatology Medicare: Medicare Enrolled Practice Location: 900 Blake Wilbur Dr Rm W0069, Stanford, CA 94305 Phone: 650-723-9913 |
Dr. Sierra Mei Lin Centkowski, MD Dermatology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Paige Wheaton Wolstencroft, MD Dermatology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Dr. Suzanne Michelle Sachsman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
Leandra Alicia Barnes, MD Dermatology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |
News Archive
Scientists have uncovered an alternative source for some of the damage associated with multiple sclerosis, an incurable neuroinflammatory disorder. The research, published online by Cell Press on September 23rd in the journal Immunity, reveals a direct interaction between immune cells and neurons that plays a significant role in neuronal injury and may respond to therapeutic intervention.
ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced initial safety and preliminary anti-tumor activity from the FORWARD II expansion cohort assessing mirvetuximab soravtansine in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab).
Following the broadcast of the ABC's Four Corners episode last night on complementary medicines, NPS MedicineWise is reminding people to take these medicines with care.
Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). The multi-center, randomized, placebo-controlled, double-blind trial is known as the REVERSE Trial.
› Verified 2 days ago